Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy

2018
journal article
article
24
dc.affiliationWydział Lekarski : Klinika Hematologiipl
dc.cm.date2020-01-07
dc.cm.id90669
dc.contributor.authorWalewski, Janpl
dc.contributor.authorHellman, Andrzejpl
dc.contributor.authorSiritanaratkul, Noppadolpl
dc.contributor.authorOzsan, Guner Hayripl
dc.contributor.authorOzcan, Muhitpl
dc.contributor.authorChuncharunee, Supornpl
dc.contributor.authorGoh, Ai Simpl
dc.contributor.authorJurczak, Wojciech - 129923 pl
dc.contributor.authorKoren, Janpl
dc.contributor.authorPaszkiewicz-Kozik, Ewapl
dc.contributor.authorWang, Bingxiapl
dc.contributor.authorSingh, Shalinipl
dc.contributor.authorHuebner, Dirkpl
dc.contributor.authorEngert, Andreaspl
dc.contributor.authorvon Tresckow, Bastianpl
dc.date.accessioned2020-01-17T10:00:10Z
dc.date.available2020-01-17T10:00:10Z
dc.date.issued2018pl
dc.description.number3pl
dc.description.physical400-410pl
dc.description.points40pl
dc.description.volume183pl
dc.identifier.doi10.1111/bjh.15539pl
dc.identifier.eissn1365-2141pl
dc.identifier.issn0007-1048pl
dc.identifier.projectROD UJ / Opl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/143861
dc.languageengpl
dc.language.containerengpl
dc.rightsDodaję tylko opis bibliograficzny*
dc.rights.licenceBez licencji otwartego dostępu
dc.source.integratorfalse
dc.subtypeArticlepl
dc.titleProspective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapypl
dc.title.journalBritish Journal of Haematologypl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.affiliationpl
Wydział Lekarski : Klinika Hematologii
dc.cm.date
2020-01-07
dc.cm.id
90669
dc.contributor.authorpl
Walewski, Jan
dc.contributor.authorpl
Hellman, Andrzej
dc.contributor.authorpl
Siritanaratkul, Noppadol
dc.contributor.authorpl
Ozsan, Guner Hayri
dc.contributor.authorpl
Ozcan, Muhit
dc.contributor.authorpl
Chuncharunee, Suporn
dc.contributor.authorpl
Goh, Ai Sim
dc.contributor.authorpl
Jurczak, Wojciech - 129923
dc.contributor.authorpl
Koren, Jan
dc.contributor.authorpl
Paszkiewicz-Kozik, Ewa
dc.contributor.authorpl
Wang, Bingxia
dc.contributor.authorpl
Singh, Shalini
dc.contributor.authorpl
Huebner, Dirk
dc.contributor.authorpl
Engert, Andreas
dc.contributor.authorpl
von Tresckow, Bastian
dc.date.accessioned
2020-01-17T10:00:10Z
dc.date.available
2020-01-17T10:00:10Z
dc.date.issuedpl
2018
dc.description.numberpl
3
dc.description.physicalpl
400-410
dc.description.pointspl
40
dc.description.volumepl
183
dc.identifier.doipl
10.1111/bjh.15539
dc.identifier.eissnpl
1365-2141
dc.identifier.issnpl
0007-1048
dc.identifier.projectpl
ROD UJ / O
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/143861
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Dodaję tylko opis bibliograficzny
dc.rights.licence
Bez licencji otwartego dostępu
dc.source.integrator
false
dc.subtypepl
Article
dc.titlepl
Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy
dc.title.journalpl
British Journal of Haematology
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
12
Views per month
Views per city
Wroclaw
2
Ashburn
1
Des Moines
1
Dublin
1
Shanghai
1

No access

No Thumbnail Available